Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Polyplus Transfection has 1 pending office action currently active. The prosecution involves 1 distinct examiner and 0 distinct art units. This suggests a uniquely categorized examination process for the pending matter, as the lack of a recorded art unit is a distinct administrative feature of this case.
WERTZ, ASHLEE ELIZABETH is the busiest examiner for this portfolio, currently managing the pending office action. With only a single examiner involved, the prosecution is currently limited to one individual's oversight at the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WERTZ, ASHLEE ELIZABETH | 1 | 52.7% | +35.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18865240 | LIPID NANOPARTICLES COMPRISING AN IMIDAZOLIUM-BASED CATIONIC LIPID | WERTZ, ASHLEE ELIZABETH | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18865240 | LIPID NANOPARTICLES COMPRISING AN IMIDAZOLIUM-BASED CATIONIC LIPID | WERTZ, ASHLEE ELIZABETH | — | §103 | Non-Final OA | — | Pending | Nov 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPolyplus Transfection has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Ashlee Elizabeth Wertz has the most, with 1 of Polyplus Transfection's pending office actions.